Status:
COMPLETED
A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle Osteoarthritis
Lead Sponsor:
Genzyme, a Sanofi Company
Conditions:
Osteoarthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This clinical study is to evaluate the safety and efficacy of Synvisc in patients with symptomatic ankle osteoarthritis (OA). Patients will be given Synvisc, with the possible administration of a seco...
Eligibility Criteria
Inclusion
- Patients with symptomatic OA pain of ankle (talo-crural)
Exclusion
- Patients with current or prior conditions or treatments that would impede measurements of efficacy or safety
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
End Date :
February 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00131768
Start Date
November 1 2003
End Date
February 1 2006
Last Update
March 18 2015
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Sportmedizinisches Institut Frankfurt am Main e.V. Orthopadie
Frankfurt, Germany, D-60528
2
Johanna Etienne Krankenhaus
Neuss, Germany, D-41462
3
Instituti Ortopedici Rizzoli
Bologna, Italy, 40136
4
Ospedale Santa Chiara, Clinica Ortopedica, Universita di Pisa
Pisa, Italy, 56126